ScienceNot yet confirmed elsewhere1 publisher2 min readPublished
Three helicases and a tethered enzyme dismantle the human spliceosome after each intron
Structures in Nature catch human spliceosomes at two stages of termination as three helicases and the enzyme DBR1 free and debranch the spent intron. How the machine is cleared for its next round, and its intron sent to decay, had been an open question.
The Scientist · Science desk

What happened
- DBR1, tethered to the spliceosome, then debranches the intron, producing a previously unknown intermediate the authors call the debranched intron spliceosome.
- That state recruits the helicase DHX35 with GPATCH1-WDR83, helped by YJU2B, and DHX35 ejects the intron from the U6 snRNA-5' splice site duplex to drive disassembly.
- On spliceosomes stalled on aberrant introns, YJU2B instead pairs with LENG1 to guide the same DHX35-GPATCH1-WDR83 complex through a quality-control version of termination.
Why it matters
- capability With a named intermediate and a factor assigned to each step, researchers can trace a failure of intron decay or snRNA recycling to a specific helicase or partner protein.
- exposure Because routine termination and quality control share DHX35-GPATCH1-WDR83, a defect in that complex would be expected to impair both recycling and the clearance of stalled spliceosomes.
- constraint On this model, debranching depends on helicase work done first: DBR1 can reach the branch point only after DHX15 and Aquarius extract it from the RNA network.
The search for termination factors began with a clean comparison. Earlier work from the same group showed that in whole-worm extract of C. elegans, the intron-lariat spliceosome is the main spliceosome state and carries the helicase DHX15, and that adding ATP switches DHX15 on to start termination [9]. This time the team purified the ATP-treated complexes and compared them with the untreated intron-lariat spliceosome by mass spectrometry [10]. The starting complex was the same and only one ingredient was added. The treated complexes had lost all five known termination factors, TFIP11, PAXBP1, C19L1, C19L2 and DHX15 itself, and were significantly enriched in DHX35 and GPATCH1 [10].
Those two proteins mattered because nobody could explain the later steps. A spliceosome is built fresh on each intron, and after the joined mRNA leaves, the cut-out intron stays bound in the spliceosome's RNA active site [12]. The spliceosome then has to be taken apart so its proteins and snRNAs can be reused, and the intron has to be ejected, debranched at its branch-point adenosine and degraded [14]. Because the machine is assembled anew for every intron, that teardown happens every time an intron is removed [17]. Recent studies had described only the first step, recognition by four dedicated termination factors and DHX15 [13]. In those structures the branch point was buried in the spliceosome's RNA network [11]. DBR1, an essential enzyme, had been proposed to debranch the intron while it was still on the spliceosome, but that required some unknown way of pulling the branch point out first [11][15].
The pathway, as the authors report it, applies to human spliceosomes. The structures are of endogenous human complexes, and the team combined them with biochemistry, RNA sequencing and genetics [8]. The proteomic screen that flagged DHX35 and GPATCH1 ran in worm extract [10]. That split is reasonable, since the human structures carry the claim and the worm data pointed to where to look. It does mean that the human role of each factor rests on the structural and genetic evidence in human material.
Cryo-EM caught two sequential stages of termination [2], with three RNA helicases acting across them [16]. The two snapshots establish the order of states. They do not show how fast each step runs in a living cell, or which one limits how quickly snRNAs return for the next round of splicing; those rates need kinetic measurements.
What to watch
- Knockdown or mutant studies in human cells testing whether loss of DHX35, GPATCH1 or LENG1 leaves intron-bound spliceosomes accumulating.
- Kinetic measurements of each termination step, showing which one limits how fast snRNAs are recycled.
- Structural detail of how LENG1 and YJU2B recognise a spliceosome stalled on an aberrant intron.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence62
- Adoption
- Insufficient
- Hype gap+5
- Incentives
- Insufficient
- Confidence55
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
After excising an intron from pre-mRNA, the spliceosome remains trapped in a non-productive complex bound to the intron; termination of this complex is critical for spliceosome recycling and intron decay, but the mechanism had remained unknown.
- [2]
The authors present cryo-electron microscopy structures of human spliceosomes at two sequential stages of termination.
- [3]
The RNA helicases DHX15 and Aquarius unwind the RNA active site of the spliceosome, releasing bound components including U2 snRNA and extracting the buried intron-lariat branch point.
- [4]
The branch point is then debranched by the spliceosome-tethered enzyme DBR1, generating the previously unknown debranched intron spliceosome (DIS).
- [5]
The debranched intron spliceosome recruits the RNA helicase DHX35 with its co-factors GPATCH1-WDR83, assisted by YJU2B.
- [6]
DHX35 ejects the debranched intron from the U6 snRNA-5' splice site duplex, driving spliceosome disassembly and intron turnover.
- [7]
In defective spliceosomes stalled on aberrant introns, YJU2B partners with LENG1 to guide DHX35-GPATCH1-WDR83 for termination through spliceosome quality control.
- [8]
The authors combined cryo-EM of endogenous human spliceosomes with biochemistry, RNA sequencing and genetics.
- [9]
The group previously showed that the C. elegans intron-lariat spliceosome is the predominant spliceosome state in whole-worm extract and associates with DHX15; adding ATP to these extracts activates DHX15 to initiate spliceosome termination.
- [10]
ATP-treated terminating spliceosomes purified from worm extract and analysed by mass spectrometry were, compared with the intron-lariat spliceosome, depleted of the five known termination factors (TFIP11, PAXBP1, C19L1, C19L2 and DHX15) but significantly enriched in DHX35 and GPATCH1.
- [11]
In available intron-lariat spliceosome structures, the excised intron-lariat and its branch point remain sequestered within the RNA network of the spliceosome; debranching by DBR1 on the spliceosome had been proposed but would require extraction of the branch point before intron ejection through as-yet-unknown mechanisms.
- [12]
The spliceosome assembles anew on each pre-mRNA intron; although the ligated mRNA is released after catalysis, the intron-lariat remains bound within the RNA-based active site, forming the intron-lariat spliceosome.
- [13]
Recent studies uncovered the initial recognition of the intron-lariat spliceosome by four dedicated termination factors and the helicase DHX15, but subsequent termination steps remained unclear.
- [14]
To sustain subsequent rounds of splicing, the intron-lariat spliceosome must be disassembled to recycle its proteins and snRNAs, and the intron-lariat must be ejected, debranched at its branch point adenosine, and eventually degraded.
- [15]
DBR1 is an essential enzyme that debranches the intron-lariat.
- [16]
Three RNA helicases act in termination: DHX15 and Aquarius in the first stage, DHX35 in the second.
- [17]
Because a spliceosome is assembled anew on each intron and must be disassembled afterwards, termination recurs once for every intron removed.
Sources
1 independent publisher whose own reporting we read for this story.
- nature.comMechanism of spliceosome termination
1 article · October 6, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.